Millions of People Will Be Blindsided in 2022. Will You Be One of Them?

On December 7, Louis Navellier, Eric Fry & Luke Lango will reveal the major events that will rock the markets in 2022. Will your money be safe?

Tue, December 7 at 7:00PM ET

OGEN Stock Alert: 14 Things to Know About Oragenics as Shares Rocket Thursday

Oragenics (NYSEAMERICAN:OGEN) is seeing shares of its stock take off on Thursday on vaccine news for the novel coronavirus.

A doctor holds a coronavirus 2019-nCoV Blood Sample


Here’s what investors need to know about the latest OGEN stock news.

  • Oragenics has announced an agreement with Adjuvance Technologies to add adjuvant TQL1055 to its coronavirus vaccine.
  • Adjuvants are added to vaccines to increase their effectiveness.
  • TQL1055 is a semi-synthetic analogue of the saponin adjuvant QS-21.
  • The adjuvant’s positive benefits include increased stability and manufacturing efficiency.
  • Oragenics notes that it will be using TQL1055 alongside its coronavirus vaccine in animal studies.
  • This will have it testing the combination in animals as part of pre-clinical trials.
  • These trials are set to start in the first quarter of 2021 and will include hamsters and mice.
  • The deal between the two also opens up the opportunity to use TQL1055 in human trials.
  • Oragenics says that its goal is to start up clinical human trials of its coronavirus vaccine later this year.
  • OGEN says it expects a stronger response from its vaccine thanks to the addition of the adjuvant.
  • This has it expecting a more intense response with a lower antigen dose.
  • In addition to treating the novel coronavirus, Oragenics believes the vaccine could have uses in treating other strains of the virus.
  • The vaccine also supports storage and transportation at normal refrigerated temperatures.
  • That should allow for easier transport and distribution of the vaccine.

OGEN stock was up 46% as of Thursday morning.

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article.

Article printed from InvestorPlace Media,

©2021 InvestorPlace Media, LLC